1. Home
  2. APLS vs BCO Comparison

APLS vs BCO Comparison

Compare APLS & BCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLS
  • BCO
  • Stock Information
  • Founded
  • APLS 2009
  • BCO 1859
  • Country
  • APLS United States
  • BCO United States
  • Employees
  • APLS N/A
  • BCO N/A
  • Industry
  • APLS Biotechnology: Pharmaceutical Preparations
  • BCO Oil Refining/Marketing
  • Sector
  • APLS Health Care
  • BCO Consumer Discretionary
  • Exchange
  • APLS Nasdaq
  • BCO Nasdaq
  • Market Cap
  • APLS 3.6B
  • BCO 4.1B
  • IPO Year
  • APLS 2017
  • BCO N/A
  • Fundamental
  • Price
  • APLS $27.52
  • BCO $91.68
  • Analyst Decision
  • APLS Buy
  • BCO Strong Buy
  • Analyst Count
  • APLS 18
  • BCO 3
  • Target Price
  • APLS $46.71
  • BCO $120.50
  • AVG Volume (30 Days)
  • APLS 1.4M
  • BCO 209.5K
  • Earning Date
  • APLS 02-28-2025
  • BCO 02-26-2025
  • Dividend Yield
  • APLS N/A
  • BCO 1.07%
  • EPS Growth
  • APLS N/A
  • BCO N/A
  • EPS
  • APLS N/A
  • BCO 2.64
  • Revenue
  • APLS $715,216,000.00
  • BCO $4,993,300,000.00
  • Revenue This Year
  • APLS $97.25
  • BCO $3.70
  • Revenue Next Year
  • APLS $12.68
  • BCO $2.61
  • P/E Ratio
  • APLS N/A
  • BCO $34.30
  • Revenue Growth
  • APLS 162.10
  • BCO 3.60
  • 52 Week Low
  • APLS $24.34
  • BCO $79.20
  • 52 Week High
  • APLS $71.90
  • BCO $115.91
  • Technical
  • Relative Strength Index (RSI)
  • APLS 38.99
  • BCO 44.68
  • Support Level
  • APLS $26.84
  • BCO $91.14
  • Resistance Level
  • APLS $28.59
  • BCO $94.89
  • Average True Range (ATR)
  • APLS 1.12
  • BCO 1.96
  • MACD
  • APLS -0.03
  • BCO -0.03
  • Stochastic Oscillator
  • APLS 18.09
  • BCO 34.58

About APLS Apellis Pharmaceuticals Inc.

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

About BCO Brinks Company (The)

The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.

Share on Social Networks: